Embraer reported record third-quarter 2026 revenues of $2.35 billion, a 17% increase year-over-year, driven by strong aircraft deliveries totaling 66 units. The company raised its full-year revenue guidance to $8.4-$8.6 billion and boosted its adjusted free cash flow target to $700 million or more, reflecting improved operational performance. Embraer's firm order backlog hit an all-time high of $35.7 billion, signaling robust demand ahead. The company maintains its delivery targets for commercial and executive aviation aircraft for 2026.
Embraer earnings results provide context for readers. For those following Industrials-sector US stocks on Pluang, 63 out of 135 rose and 61 fell as of Nov 10, 2026 17:21 WIB. Notable movers include FLNC at USD 5.50 with a 1.85% increase and SEB at USD 3,850.00 with a 1.75% rise, while RDW declined 1.72% to USD 8.01 with 70% sell activity and a typical hold time of 21 days.
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...
Registration is now open for Brand Licensing Expo 2027, scheduled for May 25-27 at Mandalay Bay, Las Vegas. The event, rebranded from Licensing Expo, features over 265 confirmed exhibitors including major brands like Amazon MGM Studios, Coca-Cola, an...
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...
